China is becoming a major force in global drug innovation.
In the first half of 2026, Chinese companies secured eight of the world's ten largest pharmaceutical out-licensing deals, worth a record $110 billion.
It is happening despite growing US scrutiny over Chinese clinical data.
Why is global drugmakers betting big on China?
And where do cutting-edge AI and traditional medicine fit into the global race to treat disease?
CGTN's Huang Fei explains.
šŗ Subscribe to our YouTube channel and stay updated with our latest analysis and interviews:š
https://www.youtube.com/channel/UCgrNz-aDmcr2uuto8_DL2jg š
Download our APP on Apple Store (iOS): https://itunes.apple.com/us/app/cctvnews-app/id922456579?l=zh&ls=1&mt=8
Download our APP on Google Play (Android): https://play.google.com/store/apps/details?id=com.imib.cctv
For more:
https://www.cgtn.com/video
Most watched videos:
Impossible Challenge: 30 seconds to count banknotes BLINDFOLDED
https://www.youtube.com/watch?v=ZmP_Ybj-jws
Impossible Challenge: Gymnastics Boy Arat Hosseini from Iran!
https://www.youtube.com/watch?v=8sxX--U4c8w
Impossible Challenge: How to calm babies in 5 seconds?
https://www.youtube.com/watch?v=kR3q9sXM7WA